Breaking News Instant updates and real-time market news.

NEXT

NextDecade

$3.05 /

-0.25 (-7.58%)

18:22
08/03/21
08/03
18:22
08/03/21
18:22

NextDecade comments on U.S. Court of Appeals order

The company states: "Today, the U.S. Court of Appeals for the D.C. Circuit issued an order and a separate opinion related to the Federal Energy Regulatory Commission's, or FERC, authorization of NextDecade's Rio Grande LNG export project. In the order and separate opinion, the Court rejected all but two of the claims put forward by RGLNG's opponents. The Court asked FERC to further explain two technical items related to climate change and environmental justice. In its conclusion, the Court expressly stated that it is "reasonably likely" that on remand FERC can address the two identified deficiencies "while reaching the same result." NextDecade CEO Matt Schatzman states: "We are pleased the Court affirmed the validity of the FERC authorization of our Rio Grande LNG project and we look forward to the FERC's response to the Court's requests. Efforts to reduce global greenhouse gas emissions are at the very foundation of our company and we have already announced actions to reduce emissions at Rio Grande LNG by more than 90% through use of carbon capture and storage."

NEXT NextDecade
$3.05 /

-0.25 (-7.58%)

06/08/21 Evercore ISI
NextDecade upgraded to Outperform from In Line at Evercore ISI
06/07/21 Morgan Stanley
Morgan Stanley upgraded Tellurian to Equal Weight, quadruples price target to $8
06/07/21 Morgan Stanley
Morgan Stanley upgrades NextDecade to Overweight, triples price target to $6
06/07/21 Morgan Stanley
NextDecade upgraded to Overweight from Equal Weight at Morgan Stanley

TODAY'S FREE FLY STORIES

Options
Noodles & Company options imply 7.7% move in share price post-earnings » 15:25
10/27/21
10/27
15:25
10/27/21
15:25
NDLS

Noodles & Company

$12.46 /

-0.2 (-1.58%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

10/06/21 Piper Sandler
Noodles & Company price target raised to $15 from $14 at Piper Sandler
10/05/21 Stephens
Noodles & Company initiated with an Overweight at Stephens
05/26/21 Sidoti
Noodles & Company initiated with a Buy at Sidoti
03/11/21 Piper Sandler
Noodles & Company upgraded to Overweight from Neutral at Piper Sandler
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

  • 16
    Dec
  • 01
    Dec
NDLS Noodles & Company
$12.46 /

-0.2 (-1.58%)

Options
ArcelorMittal call volume above normal and directionally bullish » 15:25
10/27/21
10/27
15:25
10/27/21
15:25
MT

ArcelorMittal

$33.37 /

-0.545 (-1.61%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

10/14/21
Fly Intel: Top five analyst downgrades
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
ArcelorMittal downgraded to Sector Weight from Overweight at KeyBanc
10/14/21 Credit Suisse
ArcelorMittal upgraded to Outperform from Neutral at Credit Suisse
MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

MT ArcelorMittal
$33.37 /

-0.545 (-1.61%)

Periodicals
Feds probing Novartis over Entresto marketing, doctor compensation, Stat says » 15:23
10/27/21
10/27
15:23
10/27/21
15:23
NVS

Novartis

$83.08 /

-1.77 (-2.09%)

Federal investigators…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

14:22 Today JPMorgan
Novartis price target lowered to CHF 80 from CHF 84 at JPMorgan
10/12/21 Berenberg
Novartis price target lowered to CHF 88 from CHF 96 at Berenberg
10/08/21 UBS
Novartis price target lowered to CHF 92 from CHF 95 at UBS
09/29/21 Stifel
Blueprint Medicines rersumed with a Hold at Stifel
NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

NVS Novartis
$83.08 /

-1.77 (-2.09%)

On The Fly
Fly Intel: What to watch in Comcast earnings report » 15:20
10/27/21
10/27
15:20
10/27/21
15:20
CMCSA

Comcast

$52.88 /

-0.87 (-1.62%)

, CHTR

Charter

$720.54 /

-7.42 (-1.02%)

, ATUS

Altice USA

$17.11 /

-0.48 (-2.73%)

, ROKU

Roku

$318.50 /

-5.53 (-1.71%)

, VZIO

Vizio

$20.40 /

+0.21 (+1.04%)

Media giant,…

ShowHide Related Items >><<
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
10/12/21 Deutsche Bank
Comcast price target lowered to $64 from $68 at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CHTR Charter
$720.54 /

-7.42 (-1.02%)

10/12/21 Deutsche Bank
Deutsche downgrades Charter on end to favorable cable environment
10/12/21 Deutsche Bank
Charter downgraded to Hold from Buy at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Charter downgraded to Market Perform from Outperform at Raymond James
ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

10/19/21 Citi
Altice USA price target lowered to $21 from $34 at Citi
10/15/21 Pivotal Research
Altice USA price target lowered to $30 from $47 at Pivotal Research
10/12/21 Deutsche Bank
Deutsche downgrades Altice USA on end to favorable cable environment
10/12/21 Deutsche Bank
Altice USA downgraded to Hold from Buy at Deutsche Bank
ROKU Roku
$318.50 /

-5.53 (-1.71%)

10/21/21 Stephens
Roku sits in 'more enviable' position in fight over YouTube TV, says Stephens
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
09/30/21 Cleveland Research
Roku initiated with a Buy at Cleveland Research
09/27/21 BofA
Roku selloff overdone as streaming lead remains, says BofA
VZIO Vizio
$20.40 /

+0.21 (+1.04%)

10/11/21 Stephens
Vizio CTO exit not tied to any recent underperformance, says Stephens
10/07/21 Stephens
Comcast-branded Smart TV Launch in U.S. 'likely imminent,' says Stephens
09/20/21
Fly Intel: Top five analyst initiations
09/20/21 Cannonball Research
Vizio initiated with a Neutral at Cannonball Research
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

  • 24
    Aug
  • 25
    Mar
CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

CHTR Charter
$720.54 /

-7.42 (-1.02%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

CMCSA Comcast
$52.88 /

-0.87 (-1.62%)

ATUS Altice USA
$17.11 /

-0.48 (-2.73%)

ROKU Roku
$318.50 /

-5.53 (-1.71%)

VZIO Vizio
$20.40 /

+0.21 (+1.04%)

Options
Encompass Health options imply 8.1% move in share price post-earnings » 15:19
10/27/21
10/27
15:19
10/27/21
15:19
EHC

Encompass Health

$65.96 /

-1.93 (-2.84%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

10/13/21 Truist
Encompass Health price target lowered to $88 from $100 at Truist
09/23/21 UBS
Encompass Health initiated with Buy, $98 target at UBS
09/23/21 UBS
Encompass Health initiated with a Buy at UBS
08/02/21 Raymond James
Encompass Health upgraded to Strong Buy from Outperform at Raymond James
EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

EHC Encompass Health
$65.96 /

-1.93 (-2.84%)

Technical Analysis
NASDAQ market internals summary » 15:17
10/27/21
10/27
15:17
10/27/21
15:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 15:16
10/27/21
10/27
15:16
10/27/21
15:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Hot Stocks
IronNet spikes 37% after announcing joining Microsoft Intelligent Security Assoc » 15:12
10/27/21
10/27
15:12
10/27/21
15:12
IRNT

IronNet

$13.81 /

+3.48 (+33.69%)

, MSFT

Microsoft

$325.37 /

+15.53 (+5.01%)

IronNet (IRNT) jumped 37%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

09/29/21
Fly Intel: Top five analyst initiations
09/29/21 Jefferies
IronNet initiated with a Hold at Jefferies
09/27/21 Needham
IronNet initiated with a Buy at Needham
09/27/21 Needham
IronNet initiated with a Buy at Needham
MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

09:13 Today Wedbush
Microsoft delivers another 'World-Series' cloud performance, says Wedbush
08:41 Today Credit Suisse
Microsoft price target raised to $340 from $320 at Credit Suisse
08:33 Today Morgan Stanley
Microsoft price target raised to $364 from $331 at Morgan Stanley
08:24 Today Evercore ISI
Microsoft price target raised to $370 from $325 at Evercore ISI
MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

IRNT IronNet
$13.81 /

+3.48 (+33.69%)

MSFT Microsoft
$325.37 /

+15.53 (+5.01%)

Options
Digimarc options imply 9.4% move in share price post-earnings » 15:11
10/27/21
10/27
15:11
10/27/21
15:11
DMRC

Digimarc

$46.78 /

-1.11 (-2.32%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

10/29/20 Craig-Hallum
Digimarc price target raised to $23 from $13 at Craig-Hallum
DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

DMRC Digimarc
$46.78 /

-1.11 (-2.32%)

Recommendations
UBS price target raised to CHF 20 from CHF 19 at RBC Capital » 15:10
10/27/21
10/27
15:10
10/27/21
15:10
UBS

UBS

$18.12 /

+0.16 (+0.89%)

RBC Capital analyst Anke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

14:59 Today Barclays
UBS price target raised to CHF 16.50 from CHF 15 at Barclays
14:09 Today Credit Suisse
UBS price target raised to CHF 19.50 from CHF 18.50 at Credit Suisse
13:44 Today Deutsche Bank
UBS price target raised to CHF 19 from CHF 18 at Deutsche Bank
10/26/21 DZ Bank
UBS downgraded to Hold from Buy at DZ Bank
UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

UBS UBS
$18.12 /

+0.16 (+0.89%)

Recommendations
Reckitt Benckiser price target lowered to 6.200 GBp at RBC Capital » 15:09
10/27/21
10/27
15:09
10/27/21
15:09
RBGLY

Reckitt Benckiser

$15.96 /

+0.87 (+5.77%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

14:57 Today Barclays
Reckitt Benckiser price target lowered to 8,900 GBp from 9,500 GBp at Barclays
10/01/21 UBS
Reckitt Benckiser price target lowered to 7,600 GBp from 8,000 GBp at UBS
09/20/21 Barclays
Reckitt Benckiser price target lowered to 9,500 GBp from 9,800 GBp at Barclays
09/16/21 Deutsche Bank
Reckitt Benckiser named short-term investment idea at Deutsche Bank
Recommendations
HSBC price target raised to 490 GBp from 460 GBp at RBC Capital » 15:09
10/27/21
10/27
15:09
10/27/21
15:09
HSBC

HSBC

$30.51 /

-0.21 (-0.68%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

10/26/21 JPMorgan
HSBC price target raised to 450 GBp from 440 GBp at JPMorgan
10/22/21 Investec
HSBC downgraded to Hold from Buy at Investec
10/15/21 Barclays
HSBC price target raised to 550 GBp from 530 GBp at Barclays
10/14/21 BofA
BofA upgrades HSBC to Buy, raises forecasts on recent rate moves
HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

HSBC HSBC
$30.51 /

-0.21 (-0.68%)

Recommendations
Davide Campari-Milano price target raised to EUR 10 at RBC Capital » 15:08
10/27/21
10/27
15:08
10/27/21
15:08
DVDCF

Davide Campari-Milano

$14.40 /

-0.61 (-4.06%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$14.40 /

-0.61 (-4.06%)

DVDCF Davide Campari-Milano
$14.40 /

-0.61 (-4.06%)

14:44 Today Barclays
Davide Campari-Milano price target raised to EUR 12.90 at Barclays
10/14/21 JPMorgan
Davide Campari-Milano price target raised to EUR 14 from EUR 13 at JPMorgan
10/08/21 Barclays
Davide Campari-Milano price target raised to EUR 12.50 from EUR 12 at Barclays
10/05/21 AlphaValue/Baader
Davide Campari-Milano upgraded to Reduce from Sell at AlphaValue/Baader
Recommendations
Alfa Laval price target raised to SEK 400 from SEK 370 at RBC Capital » 15:08
10/27/21
10/27
15:08
10/27/21
15:08
ALFVY

Alfa Laval

$40.25 /

+1.8 (+4.68%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$40.25 /

+1.8 (+4.68%)

09/28/21 Morgan Stanley
Alfa Laval price target raised to SEK 312 from SEK 300 at Morgan Stanley
09/06/21 Credit Suisse
Alfa Laval downgraded to Neutral from Outperform at Credit Suisse
08/03/21 Barclays
Alfa Laval price target raised to SEK 320 from SEK 270 at Barclays
07/22/21 JPMorgan
Alfa Laval price target raised to SEK 310 from SEK 250 at JPMorgan
Options
Sleep Number options imply 9.7% move in share price post-earnings » 15:04
10/27/21
10/27
15:04
10/27/21
15:04
SNBR

Sleep Number

$89.52 /

-1.33 (-1.46%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

07/21/21 Piper Sandler
Sleep Number price target lowered to $135 from $165 at Piper Sandler
02/18/21
Fly Intel: Top five analyst upgrades
02/18/21 Wedbush
Sleep Number price target raised to $130 from $120 at Wedbush
02/18/21 Piper Sandler
Sleep Number price target raised to $165 from $108 at Piper Sandler
SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

SNBR Sleep Number
$89.52 /

-1.33 (-1.46%)

Hot Stocks
Allegiant Travel: Maintenace technicians workers vote to ratify contract » 15:03
10/27/21
10/27
15:03
10/27/21
15:03
ALGT

Allegiant Travel

$180.00 /

-0.77 (-0.43%)

Allegiant announces that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$180.00 /

-0.77 (-0.43%)

ALGT Allegiant Travel
$180.00 /

-0.77 (-0.43%)

10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/12/21 Deutsche Bank
Allegiant Travel price target lowered to $275 from $285 at Deutsche Bank
10/06/21 Wolfe Research
Allegiant Travel downgraded to Peer Perform on valuation at Wolfe Research
10/06/21 Wolfe Research
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research
ALGT Allegiant Travel
$180.00 /

-0.77 (-0.43%)

  • 06
    May
ALGT Allegiant Travel
$180.00 /

-0.77 (-0.43%)

Hot Stocks
Valley National reports regulatory approvals for Westchester Bank acquisition » 15:00
10/27/21
10/27
15:00
10/27/21
15:00
VLY

Valley National

$13.48 /

-0.425 (-3.06%)

Valley National Bancorp,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VLY Valley National
$13.48 /

-0.425 (-3.06%)

VLY Valley National
$13.48 /

-0.425 (-3.06%)

09/24/21 Citi
Valley National upgraded to Neutral from Sell at Citi
09/17/21 Hovde Group
Valley National upgraded to Outperform from Market Perform at Hovde Group
04/14/21 Citi
Valley National price target raised to $12 from $9 at Citi
02/09/21 Keefe Bruyette
Valley National transferred with Outperform at Keefe Bruyette
VLY Valley National
$13.48 /

-0.425 (-3.06%)

Recommendations
Victrex price target lowered to 2,140 GBp from 2,150 GBp at Barclays » 15:00
10/27/21
10/27
15:00
10/27/21
15:00
VTXPF

Victrex

$31.38 /

+ (+0.00%)

Barclays analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTXPF Victrex
$31.38 /

+ (+0.00%)

10/13/21 UBS
Victrex price target lowered to 2,170 GBp from 2,200 GBp at UBS
08/12/21 Morgan Stanley
Victrex assumed with an Equal Weight at Morgan Stanley
07/15/21 Morgan Stanley
Victrex price target lowered to 2,130 GBp from 2,230 GBp at Morgan Stanley
07/13/21 Berenberg
Victrex price target raised to 2,600 GBp from 2,500 GBp at Berenberg
Recommendations
UBS price target raised to CHF 16.50 from CHF 15 at Barclays » 14:59
10/27/21
10/27
14:59
10/27/21
14:59
UBS

UBS

$18.13 /

+0.17 (+0.95%)

Barclays analyst Amit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$18.13 /

+0.17 (+0.95%)

UBS UBS
$18.13 /

+0.17 (+0.95%)

14:09 Today Credit Suisse
UBS price target raised to CHF 19.50 from CHF 18.50 at Credit Suisse
13:44 Today Deutsche Bank
UBS price target raised to CHF 19 from CHF 18 at Deutsche Bank
10/26/21 DZ Bank
UBS downgraded to Hold from Buy at DZ Bank
10/18/21 Credit Suisse
UBS price target raised to CHF 18.50 from CHF 18 at Credit Suisse
UBS UBS
$18.13 /

+0.17 (+0.95%)

UBS UBS
$18.13 /

+0.17 (+0.95%)

UBS UBS
$18.13 /

+0.17 (+0.95%)

Hot Stocks
Shell acknowledges Third Point letter, 'welcomes open dialogue' » 14:59
10/27/21
10/27
14:59
10/27/21
14:59
RDS.A

Royal Dutch Shell

$49.90 /

+1.05 (+2.15%)

, RDS.B

Royal Dutch Shell

$49.75 /

+0.72 (+1.47%)

Royal Dutch Shell notes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDS.A Royal Dutch Shell
$49.90 /

+1.05 (+2.15%)

RDS.B Royal Dutch Shell
$49.75 /

+0.72 (+1.47%)

RDS.A Royal Dutch Shell
$49.90 /

+1.05 (+2.15%)

10/25/21 Citi
Royal Dutch Shell price target raised to 1,710 GBp from 1,430 GBp at Citi
10/25/21 TD Securities
BP initiated with a Hold at TD Securities
10/25/21 TD Securities
Royal Dutch Shell initiated with a Buy at TD Securities
10/12/21 Morgan Stanley
Royal Dutch Shell price target raised to 2,089 GBp at Morgan Stanley
RDS.B Royal Dutch Shell
$49.75 /

+0.72 (+1.47%)

10/11/21 JPMorgan
Royal Dutch Shell price target raised to 2,300 GBp from 2,150 GBp at JPMorgan
09/23/21 JPMorgan
Royal Dutch Shell price target raised to 2,150 GBp from 2,100 GBp at JPMorgan
09/21/21 Credit Suisse
ConocoPhillips price target raised to $80 from $74 at Credit Suisse
09/17/21 JPMorgan
Royal Dutch Shell price target lowered to 2,100 GBp from 2,200 GBp at JPMorgan
RDS.A Royal Dutch Shell
$49.90 /

+1.05 (+2.15%)

RDS.B Royal Dutch Shell
$49.75 /

+0.72 (+1.47%)

RDS.A Royal Dutch Shell
$49.90 /

+1.05 (+2.15%)

RDS.B Royal Dutch Shell
$49.75 /

+0.72 (+1.47%)

RDS.A Royal Dutch Shell
$49.90 /

+1.05 (+2.15%)

RDS.B Royal Dutch Shell
$49.75 /

+0.72 (+1.47%)

Recommendations
Software AG price target lowered to EUR 35.30 from EUR 37 at Barclays » 14:58
10/27/21
10/27
14:58
10/27/21
14:58
STWRY

Software AG

$11.77 /

+ (+0.00%)

Barclays analyst Sven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STWRY Software AG
$11.77 /

+ (+0.00%)

10/26/21 UBS
Software AG price target raised to EUR 44.50 from EUR 44 at UBS
10/26/21 UBS
Software AG price target raised to EUR 44.50 from EUR 44 at UBS
10/06/21 Deutsche Bank
Software AG price target raised to EUR 36 from EUR 33 at Deutsche Bank
08/26/21 Barclays
Software AG price target raised to EUR 37 from EUR 34.80 at Barclays
Recommendations
InflaRx's updated vilobelimab data 'encouraging,' says Guggenheim » 14:58
10/27/21
10/27
14:58
10/27/21
14:58
IFRX

InflaRx

$2.94 /

+0.07 (+2.44%)

Guggenheim analyst Yatin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IFRX InflaRx
$2.94 /

+0.07 (+2.44%)

IFRX InflaRx
$2.94 /

+0.07 (+2.44%)

03/26/21 H.C. Wainwright
InflaRx price target lowered to $10 from $12 at H.C. Wainwright
03/11/21 Guggenheim
InflaRx upgraded to Buy from Neutral at Guggenheim
01/12/21 H.C. Wainwright
InflaRx price target raised to $12 from $11 at H.C. Wainwright
11/06/20 SVB Leerink
InflaRx upgraded to Outperform from Market Perform at SVB Leerink
IFRX InflaRx
$2.94 /

+0.07 (+2.44%)

  • 25
    Feb
Recommendations
Reckitt Benckiser price target lowered to 8,900 GBp from 9,500 GBp at Barclays » 14:57
10/27/21
10/27
14:57
10/27/21
14:57
RBGLY

Reckitt Benckiser

$15.96 /

+0.87 (+5.77%)

Barclays analyst Iain…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

RBGLY Reckitt Benckiser
$15.96 /

+0.87 (+5.77%)

10/01/21 UBS
Reckitt Benckiser price target lowered to 7,600 GBp from 8,000 GBp at UBS
09/20/21 Barclays
Reckitt Benckiser price target lowered to 9,500 GBp from 9,800 GBp at Barclays
09/16/21 Deutsche Bank
Reckitt Benckiser named short-term investment idea at Deutsche Bank
08/11/21 Morgan Stanley
Reckitt Benckiser price target lowered to 6,900 GBp at Morgan Stanley
Periodicals
Facebook instructs staff to save all communications for legal reasons, NYT says » 14:56
10/27/21
10/27
14:56
10/27/21
14:56
FB

Facebook

$315.20 /

-0.5 (-0.16%)

Facebook has told…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$315.20 /

-0.5 (-0.16%)

FB Facebook
$315.20 /

-0.5 (-0.16%)

07:16 Today Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
FB Facebook
$315.20 /

-0.5 (-0.16%)

FB Facebook
$315.20 /

-0.5 (-0.16%)

FB Facebook
$315.20 /

-0.5 (-0.16%)

FB Facebook
$315.20 /

-0.5 (-0.16%)

Recommendations
Ambarella price target raised to $220 from $140 at Needham » 14:56
10/27/21
10/27
14:56
10/27/21
14:56
AMBA

Ambarella

$184.98 /

+4.24 (+2.35%)

Needham analyst N. Quinn…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$184.98 /

+4.24 (+2.35%)

AMBA Ambarella
$184.98 /

+4.24 (+2.35%)

08:34 Today Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
07:53 Today Stifel
Ambarella price target raised to $200 after Oculii deal at Stifel
10/19/21 Stifel
Ambarella price target raised to $185 from $145 at Stifel
09/22/21
Fly Intel: Top five analyst upgrades
AMBA Ambarella
$184.98 /

+4.24 (+2.35%)

AMBA Ambarella
$184.98 /

+4.24 (+2.35%)

AMBA Ambarella
$184.98 /

+4.24 (+2.35%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.